Lisa Bodei
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications
Most-Cited Works
- → Radiopharmaceutical therapy in cancer: clinical advances and challenges(2020)869 cited
- → The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours(2013)798 cited
- → Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors(2014)456 cited
- → Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors(2008)419 cited
- → Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study(2011)417 cited
- Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.(2005)
- → EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)